

Unaudited	For the quarter ended
	March 31,			June 30,			September 30,			December 31,
2015
Net sales	$	7,837		$	7,121		$	4,873		$	5,299
Cost of goods sold	4,516			4,103			3,084			3,409
Income from continuing operations before income taxes	1,551		^2,3,4,5	1,234		^2,6,7	227		^2,3	(421		)	^3,6,7,8
Net income	1,035			945			235			(256		)
Basic earnings per share of common stock from continuing operations¹	1.12			1.07			0.14			(0.26		)
Diluted earnings per share of common stock from continuing operations¹	1.11			1.06			0.14			(0.26		)
2014
Net sales	$	8,594		$	8,058		$	5,905		$	5,849
Cost of goods sold	4,862			4,790			3,698			3,673
Income from continuing operations before income taxes	1,610		⁹	1,245		^9,10,11,12	634		⁹	824			^{9,12,13,14,15}
Net income	1,445			1,074			434			683
Basic earnings per share of common stock from continuing operations¹	1.40			1.01			0.36			0.63
Diluted earnings per share of common stock from continuing operations¹	1.39			1.00			0.36			0.63


^1.	Earnings per share for the year may not equal the sum of quarterly earnings per share due to changes in average share calculations.


^2.	First and third quarter 2015 included charges of $(12) and $(9), respectively, recorded in other operating charges associated with transaction costs related to the separation of the Performance Chemicals segment. Second quarter 2015 included charges of $(5) recorded in other operating charges and $(20) recorded in interest expense. See Note 3 for additional information.

^3.

First and third quarter 2015 included net insurance recoveries of $35 and $147 , respectively, recorded in other operating charges in the Agriculture segment, for recovery of costs for customer claims related to the use of the Imprelis^®herbicide. Fourth quarter 2015 included a benefit of $130 in other operating charges for reduction in accrual for customer claims related to the use of the Agriculture segment’s Imprelis^®herbicide. See Note 16 for additional information.


^4.	First quarter 2015 included a $(37) pre-tax impairment charge recorded in employee separation / asset related charges, net for a cost basis investment. See Note 4 for additional information.


^5.	First quarter 2015 included a $(40) pre-tax charge within other income, net associated with the re-measurement of the Ukraine hyrvnia net monetary assets.

^6.

Second and fourth quarter 2015 included a $(2) and $23 restructuring (charge) benefit associated with the 2014 restructuring program, recorded in employee separation / asset related charges, net. Fourth quarter 2015 included a $(798) restructuring charge consisting of $(793) recorded in employee separation/asset related charges, net and $(5) recorded in other income, net associated with structural actions across all businesses and staff functions globally to operate more efficiently by further consolidating businesses and aligning staff functions more closely with them. See Note 4 for additional information.


^7.	Second and fourth quarter 2015 included gains of $112 and $33, respectively, net of legal expenses, recorded in other income, net related to the company's settlement of a legal claim. This matter relates to the Safety & Protection segment.


^8.	Fourth quarter 2015 included charges of $(10) recorded in selling, general and administrative expenses related to transaction costs associated with the planned merger with the Dow Chemical Company announced on December 11, 2015. See Note 2 for additional information.


^9.	First, second, third and fourth quarter 2014 included charges of $(3), $(4), $(10), and $(16), respectively, recorded in other operating charges associated with transaction costs related to the separation of the Performance Chemicals segment. See Note 3 for additional information.


^10.	Second quarter 2014 included a $(58) pre-tax charge within other income, net associated with the re-measurement of Venezuelan Bolivar net monetary assets.


^11.	Second quarter 2014 included a gain of $391 recorded in other income, net associated with the sale of Glass Laminating Solutions/Vinyls. See Note 3 for additional information.

^12.

Second and Fourth quarter 2014 included a $(244) and $(297) restructuring charge, respectively, as a result of the company's plan to reduce residual costs associated with the separation of the Performance Chemicals segment and to improve productivity across all businesses and functions. The second quarter 2014 charge is recorded in employee separation/asset related charges, net. The fourth quarter 2014 restructuring charge of $(297) consists of $(232) recorded in employee separation/asset related charges, net, and $(65) recorded in other income, net. See Note 4 for additional information.


^13.	Fourth quarter 2014 included income of $210 for insurance recoveries, recorded within other operating charges, associated with the recovery of costs for customer claims related to the use of Imprelis^®. See Note 16 for additional information.


^14.	Fourth quarter 2014 included a gain of $240 recorded in other income, net associated with the sale of the copperfungicide and land management businesses, both within the Agriculture segment.


^15.	Fourth quarter 2014 included a $70 adjustment to lower performance-based compensation expense.